Profil
Qi Hui founded Focus-X Therapeutics, Inc. in 2020, where he is working as Chief Operating Officer & Director from 2020.
Postes actifs de Qi Hui
| Sociétés | Poste | Début |
|---|---|---|
Focus-X Therapeutics, Inc.
 Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Fondateur | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Focus-X Therapeutics, Inc.
Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Health Technology |
